You are here: Industry Insights > diabetes drug

News List

EU approves AZ’ Bydureon BCise device pharmatimes
September 14, 2018
AstraZeneca says the European Commission has approved a new formulation of its once-weekly diabetes drug Bydureon.
Zydus Cadila gets tentative nod from USFDA for diabetes drug financialexpress
September 12, 2018
The company has received tentative approval from the United States Food and Drug Administration (USFDA) for Sitagliptin tablets
Novo CEO: Expect U.S. diabetes drug prices to continue their downward spiral next year fiercepharma
August 09, 2018
Price-pressured Novo Nordisk expects basal insulin prices to sink even further next year—but that shouldn’t surprise investors too much, the company’s CEO says.
Metformin reverses established lung fibrosis europeanpharmaceuticalreview
July 03, 2018
A diabetes drug suggests a potential therapy for idiopathic pulmonary fibrosis…
Hua Medicine picks Hong Kong, S.A.R., China for IPO biospectrumasia
March 12, 2018
The offering could raise as much as $300 million.
Diabetes drug use during pregnancy linked to child’s weight europeanpharmaceuticalreview
March 01, 2018
When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity…
Hua Medicine of Shanghai to Raise $200M to Support Novel Diabetes Drug biospace
January 16, 2018
Hua Medicine of Shanghai expects to spend $200 million over the next three years on its novel oral diabetes 2 treatment, dorzagliatin
Novo Nordisk's new semaglutide trounces Lilly's scrappy Trulicity in diabetes trial fiercepharma
August 18, 2017
Novo Nordisk is counting on semaglutide, its forthcoming GLP-1 diabetes drug, to drive growth over the next few years, and data from the trial Sustain-7 should help.
Diabetes drug trial needs to widen participants to understand full impact europeanpharmaceuticalreview
June 26, 2017
More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research finds…
Interpretation of the Diabetes Drug Market: Increasingly Monopolized, but Still Vibrant en-cphi
March 03, 2017
Diabetes is a global public health problem. The global diabetes patients according to the statistics of the World Health Organization reach as high as 400 million.

Previous page 1 2 Next page